BioMed Research International

BioMed Research International / 2013 / Article

Research Article | Open Access

Volume 2013 |Article ID 801214 |

Rossella Bengalli, Paride Mantecca, Marina Camatini, Maurizio Gualtieri, "Effect of Nanoparticles and Environmental Particles on a Cocultures Model of the Air-Blood Barrier", BioMed Research International, vol. 2013, Article ID 801214, 8 pages, 2013.

Effect of Nanoparticles and Environmental Particles on a Cocultures Model of the Air-Blood Barrier

Academic Editor: Kazim Husain
Received14 Aug 2012
Revised14 Nov 2012
Accepted15 Nov 2012
Published23 Dec 2012


Exposure to engineered nanoparticles (NPs) and to ambient particles (PM) has increased significantly. During the last decades the application of nano-objects to daily-life goods and the emissions produced in highly urbanized cities have considerably augmented. As a consequence, the understanding of the possible effects of NPs and PM on human respiratory system and particularly on the air-blood barrier (ABB) has become of primary interest. The crosstalk between lung epithelial cells and underlying endothelial cells is indeed essential in determining the effects of inhaled particles. Here we report the effects of metal oxides NPs (CuO and TiO2) and of PM on an in vitro model of the ABB constituted by the type II epithelial cell line (NCI-H441) and the endothelial one (HPMEC-ST1.6R). The results demonstrate that apical exposure of alveolar cells induces significant modulation of proinflammatory proteins also in endothelial cells.

1. Introduction

Diffusion biological barriers, such as epidermis, the gastrointestinal tract, and the respiratory epithelium, are physiologically designed to separate two different compartments in order to allow the selective passage of external substances that are essential for the organisms and to protect the body from pathogens and hazardous substances.

The alveolar region is the functional area for the gas exchange. Alveolar epithelial cells form tight and adherens junctions which play a key role in the functionality of the air-blood barrier (ABB). In addition the maintenance of the integrity of the ABB is pivotal for the physiological function of the lungs and limits the passage of inhaled material to the blood circulation.

The alveolar surface is approximately 100 m2 and thus is the primary target for inhaled particles and nanoparticles. Inhaled particulate interact with the apical side of the epithelial cells and might be internalised and eventually translocated to the endothelium and to the blood circulation. Moreover, even in the absence of translocation, cell-particle interactions might determine an inflammatory status that in turn facilitates particles translocation due to the loss of the selective permeability of the epithelial cells and to an increase of the permeability of the endothelial cells [1, 2].

Several in vivo studies have reported pulmonary inflammation and lung injury in response to nanoparticles (NP) exposure. Nevertheless the specific effects on the ABB are scanty due to the complexity of a precise anatomical analysis of this region of the lung. As an alternative, simpler in vitro models of alveolar epithelium have been widely used to study important biological and functional characteristics. However the specificity of the ABB deserves more accurate analyses possibly developing a model able to mimic the interplay of epithelial and endothelial cells.

NPs have gained major attention in the last years due to the increase of their application in commercial products and biomedicine and the increased evidence that metal oxide particles are present in the environment as a consequence of human activities. Furthermore metal NPs have found in the last years an extensive use in industrial applications and as a consequence concern has been raised on their potential adverse effects on humans after accidental inhalation. Moreover monitoring analyses have highlighted the high presence of metal oxide NPs at sites surrounding factories, when compared to clean areas [3], and epidemiological studies have reported a correlation between the level of such NPs and the increase in pulmonary disease including exacerbation of bronchial asthma [4]. In vitro studies have reported cytotoxic effects for CuO NPs [5] while TiO2 NPs have been usually referred to as particles without significant biological effects [6]. However the results may be different depending on many factors such as the cell types used, NPs administration conditions, and the test sensitivity. Furthermore NPs may induce alveolar-capillary barrier injury causing disruption of alveolar and endothelial integrity which may determine the leakage of inflammatory mediators in the circulatory system [7, 8].

Particulate matter (PM) is considered one of the major environmental contaminants in different cities, and although great attention has been devoted to the fine fractions of PM, a main issue remains the potential effects of the coarse fraction (PM10) which has been reported to possess specific chemical and biological properties [9, 10]. In fact summer PM10 samples have been reported to be characterized by bacterial components and crustal elements, responsible for the production of proinflammatory effects.

In the present paper the effects of two metal oxide NPs (CuO and TiO2) and of summer PM10 sampled in Milan on a model of ABB are presented. The model consists of a human lung epithelial cell line, NCI-H441, with characteristics of both type II pneumocytes and Clara cells [11] and the human pulmonary microvascular endothelial cell line (HPMEC-ST1.6R) cultured on opposite site of a transwell filter insert [12, 13]. The ABB model has been characterized for its functional properties while particles effects have been determined by measuring the transepithelial resistance (TEER) and the release of pro-inflammatory mediators. Internalization of nanoparticles has been furthermore assessed by means of transmission electron microscopy.

2. Materials and Methods

2.1. Preparation of NPs Suspensions

nCuO (<50 nm) and nTiO2 (<100 nm) (Sigma Aldrich, Italy) were weighted and suspended in ultrapure sterile Milli-Q water at the concentration of 8 mg/mL. Suspensions were sonicated for 1 min with the sonicator bath Ultrasonic Soniprep 150 MSE (Sanyo) and then diluted in PBS + BSA (0,1% final concentration; Sigma Aldrich) in order to avoid particles agglomeration and optimize suspension stability. Working concentrations (0, 1, 10, 25, 50, 100 μg/mL) were obtained by adding NP suspensions directly to the culture medium (OptiMEM1X, 1% FBS; M199, 1% FBS; GIBCO). NPs and NPs suspensions were characterized as reported [14]. PM10 collected and characterized as previously reported [10] has been resuspended in sterile water and added directly to the culture medium.

2.2. Cells Cultures

Human pulmonary microvascular endothelial cell line HPMEC-ST1.6R was received from Dr. Ronald E. Unger (Institute of Pathology, Medical University of Mainz, Johannes Gutenberg University, Mainz, Germany) and cultured in 0,2% gelatine (Sigma Aldrich) coated flasks in M199 medium supplemented with 15% FBS (Gibco), 2 mM Glutamax I (Sigma Aldrich), 25 μg/mL sodium heparin (Sigma Aldrich; Italy), 25 μg/mL endothelial cell growth supplements (Sigma Aldrich), and 100 U/100 μg/mL Pen/Strep (Euroclone, Italy) at 37°C, 5% CO2.

The human lung adenocarcinoma cell line NCI-H441 (ATCC, USA) was maintained in OptiMEM medium (Gibco) supplemented with 10% FBS and Pen/Strep (100 U/100 μg/mL), at 37°C, 5% CO2.

2.3. In Vitro Alveolar-Capillary Barrier Model: Coculture of HPMEC-ST1.6R with NCI-H441

HPMEC-ST1.6R ( /cm2) cells were placed on the lower surface of transwell filter membranes (polyester; 0,4 μm pore size; Costar) coated with 0.2% gelatine and incubated for 2 h at 37°C and 5% CO2. The filter membranes were then turned upside down and placed in a 12-well plate filled with 1,5 mL HPMEC-ST1.6R medium (15% FBS) and incubated for 24 h.

The day after NCI-H441 ( /cm2) cells were seeded on the top surface of the transwell filters and cultured to confluence simultaneously with the HPMEC-ST1.6R seeded on the lower surface for 11 to 13 days. To induce differentiation, the NCI-H441 cell line in cocultures was treated with 1 μM Dexamethasone (Sigma Aldrich) from day 3 of cultivation. Summer PM10 (10 μg/cm2 equivalent to 22,5 μg/mL) and nCuO and nTiO2 suspensions (25 μg/mL) were added to the apical compartment at the 11th/12th day of coculture for additional 24 h. The doses of treatment have been defined accordingly to previous results we have reported for PM10 effects [10] and by dose-response curves on the single cell lines used for setting up the air-blood barrier model (data not shown).

2.4. Transepithelial Electrical Resistance (TEER) Measurements

In order to determine the integrity of the in vitro barrier the transbilayer electrical resistance (TEER) was measured with an EVOM Volt Ohm Meter (World Precision Instruments, Berlin, Germany) equipped with a EndOhm Chamber (World Precision Instruments, Berlin, Germany). After PM and NPs exposure, before TEER measurements, transwell filters were washed with PBS and incubated with M199 medium for 10 min in order to avoid alteration in TEER values due to cellular debris and to insert handling.

The TEER of polyester transwell filter membranes coated with gelatine 0.2%, without cells, was measured and set as blank. Barrier resistance readings (Ω cm2) were made by subtracting the resistance of the blank filter membrane and by multiplying the area of the insert (1.12 cm2). Resistance was reported as mean ± SE of at least three independent experiments.

2.5. Immunostaining

After 11-12 days of cultivation the apical compartment of coculture was washed in PBS and then fixed with paraformaldehyde (1%) for 20 min at RT. Cells were then permeabilized with Triton X-100 1%, TWEEN 1% in PBS + BSA 3% for 20 min at 4°C. The cells were then washed in PBS and incubated overnight at 4°C with rabbit anti-human zonula occludens-1 (ZO-1) antibody (cell signaling; 1 : 100) in PBS + BSA 1% buffer.

Cells were then washed three times in PBS and then incubated with the secondary antibody goat anti-rabbit Alexa fluor-488 (Invitrogen Molecular Probes Srl; 1 : 1000) for 1 h. For actin staining cells were incubated 1 h with phalloidin-TRIC (Sigma Aldrich, 1 : 750). Samples were mounted on a glass slide with ProLong mount (Invitrogen Srl) and observed by an AxioScope reverted microscope (Zeiss, Germany).

2.6. Cytokines Release

At the end of the exposure time cell culture media were collected and centrifuged at 1100 rpm for 5 min to remove cell debris. The final supernatants were stored at −80°C. IL-1β, IL-6, and IL-8 protein levels were determined by sandwich ELISA (Human Cytoset IL-1β, IL-6 and IL-8; Biolegend) according to the manufacturer’s instructions. Absorbance was measured and quantified by a plate reader (Multiskan Ascent, Thermo Scientific Instruments) at wavelengths of 450 and 570 nm.

2.7. Nanoparticles Uptake

Coculture samples were prepared for transmission electron microscopy (TEM) according to the standard procedures. Briefly, cells were fixed in 2,5% glutaraldehyde for 20 min at 4°C and postfixed with 1% osmium tetroxide for 1 h, followed by dehydration in graded ethanols. Samples were then embedded in Epon/Araldite resin, and ultrathin sections were cut at the ultramicrotome (Reichert Ultracut Jung E). The sections were collected on copper grids, counterstained by lead citrate and uranyl acetate, and exanimated by Jeol JEM 1220 TEM microscope operating at 80 kV equipped with a Gatan CCD camera for digital imaging.

2.8. Statistical Analysis

All the experiments have been performed in independent triplicates, and data are reported as mean ± S.E. if not otherwise specified. Statistical analyses have been performed with Sigmastat 3.1 software with ANOVA test and post hoc analysis.

3. Results

3.1. Formation of the Alveolar-Capillary Barrier

In order to estimate the integrity of the in vitro alveolar-capillary barrier the formation of tight junctions (TJs) was observed and the transepithelial electric resistance between cocultures measured.

The TJs formation was assessed by the stain of the tight junctional cytoplasmic plaque protein ZO-1. Data showed that after 11–13 days of cocultures and stimulation with Dexamethazone (1 μM), ZO-1 junctions were localized at the periphery of NCI-H441 cells as a continuous line delineating the limits of each cell (Figure 1(a)). The importance of the Dexamethazone stimulation is evident when comparing the ZO-1 staining of nonstimulated monolayer in which it is impossible to identify a clear membrane localization of ZO-1.

The formation of junctions between adjacent alveolar cells (NCI-H441) was also evident by transmission electron microscope analysis (Figure 2).

The integrity of the in vitro alveolar barrier was assessed by measuring the transepithelial electric resistance (TEER) between the cocultures. TEER was expressed as Ohm cm2, and the data showed that NCI-H441 and HPMEC-ST1.6R cocultures reached the maximum TEER at  Ω cm2 ( ) after 11–13 days of cultures (Figure 3). Preliminary data showed that the treatments with PM10 (10 μg/cm2 equivalent to 22.5 μg/mL) and with nTiO2 (25 μg/mL) did not produce significant changes in the TEER values (Figures 4(a) and 4(b)). On the contrary the TEER of the ABB treated with nCuO showed a significant reduction. The TEER value after 24 h of treatment was reduced to 514 Ω cm2 compared to the control value of 665 Ω cm2 (Figure 4(b)).

3.2. Cocultures Exposure to nCuO, nTiO2, and Summer PM10: Inflammatory Response

The ABB coculture system was treated with summer PM10 and metal oxide NPs (nCuO and nTiO2) in order to evaluate the specific inflammatory effects produced to the ABB model. The results showed that summer PM10 induced a significant increase in IL-1β release from basolateral compartment (158 pg/mL versus 28 pg/mL of the control group) while the apical compartment did not produce any IL-1β release (Figure 5).

The ABB treated with CuO showed a significant increase in IL-6 and in IL-8 release (268 pg/mL of IL-6 in treated cells supernatants versus 136 pg/m in control ones and 406 pg/mL of IL-8 in treated cells supernatants versus 83 pg/m in control ones) from the apical compartment while a significant interleukins release from the basolateral compartment was not observed (Figure 6(a)). nTiO2 induced an increase only in IL-6 (205 pg/mL in the treated group versus 136 pg/mL in control one) from the epithelial compartment (Figure 6(b)). NPs failed to induce significant release of IL-1β (data not shown).

3.3. NPs Internalization in Cocultures

NCI-H441 cells of coculture experiments exposed to CuO and TiO2 NPs showed the internalization of CuO and TiO2 NPs. Interestingly nCuO was found free in the cytoplasm (Figure 7(a)) while nTiO2 (Figure 7(b)) was compartmentalised into vesicles.

4. Discussion

4.1. Coculture Model of In Vitro Air-Blood Barrier

The need of developing new models to investigate the effect mechanisms produced by inhaled toxicants has been also recently outlined [15]. The gold standard proposed for the ABB is a coculture of primary alveolar epithelial cells and human pulmonary endothelial cells [16]. Such model is expensive and subject to differences due to the primary cells availability. Therefore the development of an ABB in vitro system replicating the architecture and functionality of the alveolar space, based on cell lines, is of particular interest for the reduction of in vivo experiment too. Here we present the data obtained by the use of a model constituted of two cell types: the alveolar type II cell line, NCI-H441 and the human pulmonary microvascular endothelial immortalised cells, HPMEC-ST1.6R. NCI-H411 is a commercially available line while HPMEC-ST1.6R has been obtained by primary human pulmonary microcirculation endothelial cells (HPMEC) transfected with the plasmids pSV3neo and pC1.neo.hTERT [17]. These endothelial cells exhibited most of the characteristics of the primary human pulmonary microvascular endothelial cultured cells [13] and have been therefore selected as representative model to establish a functional ABB.

The coculture model reached, after 11–13 days, a TEER representative of a functional barrier with a maximum of  Ω cm2, in agreement with previous reports [8, 12]. Such TEER value is reached thanks to the tight junctions (TJs) and adherens junctions (AJs) usually formed between epithelial cells via highly regulated events that establish cell differentiation (apical-basolateral membrane polarity) [18]. The immunofluorescence technique, used to evidence the epithelial cells Zonula occludens-1 (ZO-1), confirmed the integrity of the ABB. ZO-1 is one of the major cytoplasmic proteins forming the TJs and has been found to be associated with the transmembrane protein occludin and to link it to the actin-based cytoskeleton [19]. After 11–13 days of cocultures and stimulation with Dexamethazone (1 μM), ZO-1 junctions were clearly localized at the periphery of NCI-H441 cells as a continuous line surrounding each cell at its border. Moreover the transmission electron microscope images confirmed the formation of AJs among adjacent cells.

The TEER of the ABB models, exposed to TiO2 NPs or to PM10, showed no differences with respect to the controls. These data confirm that the low doses used did not induce significant cell toxicity in the epithelial cell line. On the contrary CuO NPs induced significant effects on TEER, therefore confirming the ability of the NPs to affect the functionality of the AAB. Indeed in A549 cells the same dose of nanometric CuO have been reported to induce a 30% of cell viability reduction [14, 20]. In other cell lines, CHO and HeLa cells, CuO NPs resulted to be more toxic, and the toxicity was related to the dissolution of Cu2+ ions from the particles [21]. The differences, among the effects produced on the cell lines used, are likely due to different uptake processes and/or different responsiveness to the treatment. Recently it has been reported [8] that coculture systems are less sensitive to NPs-induced cytotoxicity, therefore, the low reduction of TEER here observed could be related to an overall lower responsiveness of the NCI-441 cell line when differentiated for the ABB model. Nevertheless the ability of CuO NPs to induce a TEER reduction underlines the importance of better understanding the effects of NPs on the ABB in terms of reduction of its functionality.

4.2. Inflammatory Response

Inflammation processes are general responses to different lung diseases, even inflammation is a physiological response, and an uncontrolled inflammatory status may lead to adverse health effects. The ability of inhaled particles to induce the release of proinflammatory mediators has been largely used as marker of potential toxic effects [22, 23]. However the data available refer to monoculture of lung epithelial cells and the few data exist on lung endothelial cells.

The biochemical crosstalks between the cell types constituting the ABB are fundamental in maintaining the barrier homeostasis [2426].

The NPs ability to induce an acute inflammatory response in lungs of rodents has been reported [27, 28]. In vitro monocultures of both lung epithelial and endothelial cells have been used to define the proinflammatory potential of metal oxide NPs [23, 2931]. Nevertheless the data on significant model of ABB are rather scanty [8]. In agreement with our previous results [14] the ability of CuO and TiO2 NPs to induce a significant inflammatory response in the apical side of the ABB mode is shown. CuO NPs induced a significant release of the proinflammatory mediators, IL-6 and IL-8, and TiO2 increased only the release of IL-6 while both the NPs did not induce significant release of IL-1β. The lack of response of the basolateral side can be related to the integrity of the ABB which prevents the passage of NPs and/or ions towards the endothelial compartment although additional data are needed to elucidate the basolateral responses. However, Papritz et al. [32] showed for Cd2+ ions that, after apical exposure, the basolateral response was significant at concentrations which determined a decrease in TEER values.

Interestingly the apical treatment of the ABB with PM10 induced a basolateral release of IL-1β. This result is in accordance with others [8, 16] which obtained a basolateral response of endothelial cells after treatment of the epithelial cells at the apical side. IL-1β release confirms the biochemical crosstalk between the two sides of the membrane and supports the functionality and representativeness of our ABB model. Further studies will be needed to understand the mechanism by which PM10 induces IL-1β. Preliminary results obtained in our lab on THP-1-derived macrophages suggest that the inflammasome activation plays a central role (data not shown). The ability of PM in triggering the release of a potent inflammatory mediator such as IL-1β has to be carefully taken into account. Van Eeden et al. [33] showed a significant increase of circulating IL-1β in population exposed to high level of PM10; furthermore increased expression of IL-1β has been related to lung injury and lung tissue remodelling [34]. Our ABB model thus furnishes a suitable system to be used for studying lung damage mechanisms and systemic inflammation following exposure to environmental and engineered NPs.

4.3. NPs Internalization in Cocultures

Several in vivo and in vitro studies showed the translocation of NPs through the respiratory epithelium and the distribution of NPs in secondary organs such as liver, kidney, and brain [35]. Nevertheless there are still controversial evidences about NPs translocation through the alveolar barrier. ABB in vitro models can thus furnish a helpful system for investigating the actual translocation process across the barrier. Intake of submicrometric and nanometric particles in culture of epithelial cell has been widely reported [3638]. Our data showed that both nCuO and nTiO2 were found internalised in epithalial cells; however while nTiO2 particles were found as agglomerates in cytosolic vesicles, suggesting an endocytosis-mediated mechanism of internalization, nCuO particles were found as free aggregates in the cytoplasm [14, 39]. nCuO were found as free aggregates into the cytoplasm. This difference might be related to the higher oxidative potential of CuO NPs in comparison with TiO2 ones, and this ability may lead to a lipid peroxidation in the endosome vesicles, with a consequent presence of free CuO NPs in the cytoplasm.

However after 24 h of treatment, NPs were not found internalised in the basolateral compartment of endothelial cells. The inability of nCuO and nTiO2 to cross the membrane filter pores of 0.4 μm can be due to the tendency of NPs to form aggregates that are physically unable to pass through the membrane pores. Indeed it has been proposed that, even without a cell layer on the top of the filter, NPs which tend to agglomerate are not able to cross the membrane [40]. The same authors have demonstrated the capability of certain NPs to cross an in vitro model of ABB, in experiments that used a membrane filter with 3 μm pore size and A549 cell line, which were not able to form TJs.

Our data thus suggest that in presence of a functional ABB, the possibility of NPs to cross the barrier is rather scanty, although additional data are needed. For example, the use of air-liquid interface treatments, which drastically reduce the NPs agglomeration tendency in culture media, will be of particular interest in defining the translocation ability of nano objects.

In conclusion the ABB model reported here is a suitable system for studying the toxicological events at the alveolar level. Our date demonstrate that the two cell types are able to cross communicate, as evidenced by the IL-1β release in PM10-treated samples, although the passage of particles seems not to occur. Further studies will help to understand which molecules are responsible for the cells crosstalk and if, under different cell treatment conditions, the NPs translocation is really possible in a functional ABB.


M. Gualtieri greatly thanks Dr. Professor C. J. Kirkpatrick, M.D., Ph.D., D.S. of the Institute Of Pathology for the kind provision of the HPMEC-ST1.6R and helpful suggestion for culturing and exposure of the cells.


  1. N. A. Maniatis, A. Kotanidou, J. D. Catravas, and S. E. Orfanos, “Endothelial pathomechanisms in acute lung injury,” Vascular Pharmacology, vol. 49, no. 4–6, pp. 119–133, 2008. View at: Publisher Site | Google Scholar
  2. E. D. Crandall, M. A. Matthay, and S. Garfinkel, “Alveolar epithelial transport: basic science to clinical medicine,” American Journal of Respiratory and Critical Care Medicine, vol. 163, no. 4, pp. 1021–1029, 2001. View at: Google Scholar
  3. T. Rogaczewska and W. Matczak, “Evaluation of occupational exposure to cadmium based on air analysis of the work area. I. Cadmium oxide level in the air of work areas in a cadmium and nickel cumulator factory,” Medycyna Pracy, vol. 36, no. 4, pp. 273–279, 1985. View at: Google Scholar
  4. S. Weichenthal, A. Dufresne, and C. Infante-Rivard, “Indoor ultrafine particles and childhood asthma: exploring a potential public health concern,” Indoor Air, vol. 17, no. 2, pp. 81–91, 2007. View at: Publisher Site | Google Scholar
  5. S. Lanone, F. Rogerieux, J. Geys et al., “Comparative toxicity of 24 manufactured nanoparticles in human alveolar epithelial and macrophage cell lines,” Particle and Fibre Toxicology, vol. 6, article 14, 2009. View at: Publisher Site | Google Scholar
  6. D. B. Warheit, R. A. Hoke, C. Finlay, E. M. Donner, K. L. Reed, and C. M. Sayes, “Development of a base set of toxicity tests using ultrafine TiO2 particles as a component of nanoparticle risk management,” Toxicology Letters, vol. 171, no. 3, pp. 99–110, 2007. View at: Publisher Site | Google Scholar
  7. P. P. Simeonova and A. Erdely, “Engineered nanoparticle respiratory exposure and potential risks for cardiovascular toxicity: predictive tests and biomarkers,” Inhalation Toxicology, vol. 21, supplement 1, pp. 68–73, 2009. View at: Publisher Site | Google Scholar
  8. J. Kasper, M. I. Hermanns, C. Bantz et al., “Inflammatory and cytotoxic responses of an alveolar-capillary coculture model to silica nanoparticles: comparison with conventional monocultures,” Particle and Fibre Toxicology, vol. 8, article 6, 2011. View at: Publisher Site | Google Scholar
  9. M. Camatini, V. Corvaja, E. Pezzolato, P. Mantecca, and M. Gualtieri, “PM10-biogenic fraction drives the seasonal variation of proinflammatory response in A549 cells,” Environmental Toxicology, vol. 27, no. 2, pp. 63–73, 2012. View at: Google Scholar
  10. M. Gualtieri, A. Franzetti, P. Mantecca et al., “In vitro effects of chemical and microbiological characterized Milan particulate matter,” Procedia Environmental Sciences, vol. 4, pp. 192–197, 2011. View at: Google Scholar
  11. G. S. Pryhuber, R. Khalak, and Q. Zhao, “Regulation of surfactant proteins A and B by TNF-α and phorbol ester independent of NF-κB,” American Journal of Physiology, vol. 274, no. 2, pp. L289–L295, 1998. View at: Google Scholar
  12. M. I. Hermanns, R. E. Unger, K. Kehe, K. Peters, and C. J. Kirkpatrick, “Lung epithelial cell lines in coculture with human pulmonary microvascular endothelial cells: development of an alveolo-capillary barrier in vitro,” Laboratory Investigation, vol. 84, no. 6, pp. 736–752, 2004. View at: Publisher Site | Google Scholar
  13. R. E. Unger, V. Krump-Konvalinkova, K. Peters, and C. James Kirkpatrick, “In vitro expression of the endothelial phenotype: comparative study of primary isolated cells and cell lines, including the novel cell line HPMEC-ST1.6R,” Microvascular Research, vol. 64, no. 3, pp. 384–397, 2002. View at: Publisher Site | Google Scholar
  14. E. Moschini, M. Gualtieri, D. Gallinotti et al., “Metal oxide nanoparticles induce cytotoxic effects on human lung epithelial cells A549,” Chemical Engineering Transaction, vol. 22, pp. 29–34, 2010. View at: Google Scholar
  15. K. Bérubé, M. Aufderheide, D. Breheny et al., “In vitro models of inhalation toxicity and disease: the report of a FRAME workshop,” Alternatives to Laboratory Animals, vol. 37, no. 1, pp. 89–141, 2009. View at: Google Scholar
  16. M. I. Hermanns, S. Fuchs, M. Bock et al., “Primary human coculture model of alveolo-capillary unit to study mechanisms of injury to peripheral lung,” Cell and Tissue Research, vol. 336, no. 1, pp. 91–105, 2009. View at: Google Scholar
  17. V. Krump-Konvalinkova, F. Bittinger, R. E. Unger, K. Peters, H. A. Lehr, and C. J. Kirkpatrick, “Generation of human pulmonary microvascular endothelial cell lines,” Laboratory Investigation, vol. 81, no. 12, pp. 1717–1727, 2001. View at: Google Scholar
  18. S. Yonemura, M. Itoh, A. Nagafuchi, and S. Tsukita, “Cell-to-cell adherens junction formation and actin filament organization: similarities and differences between non-polarized fibroblasts and polarized epithelial cells,” Journal of Cell Science, vol. 108, no. 1, pp. 127–142, 1995. View at: Google Scholar
  19. A. S. Fanning, B. J. Jameson, L. A. Jesaitis, and J. M. Anderson, “The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton,” The Journal of Biological Chemistry, vol. 273, no. 45, pp. 29745–29753, 1998. View at: Publisher Site | Google Scholar
  20. M. Ahamed, M. A. Siddiqui, M. J. Akhtar, I. Ahmad, A. B. Pant, and H. A. Alhadlaq, “Genotoxic potential of copper oxide nanoparticles in human lung epithelial cells,” Biochemical and Biophysical Research Communications, vol. 396, no. 2, pp. 578–583, 2010. View at: Publisher Site | Google Scholar
  21. A. M. Studer, L. K. Limbach, L. Van Duc et al., “Nanoparticle cytotoxicity depends on intracellular solubility: comparison of stabilized copper metal and degradable copper oxide nanoparticles,” Toxicology Letters, vol. 197, no. 3, pp. 169–174, 2010. View at: Publisher Site | Google Scholar
  22. I. L. Hsiao and Y. J. Huang, “Effects of various physicochemical characteristics on the toxicities of ZnO and TiO2 nanoparticles toward human lung epithelial cells,” Science of the Total Environment, vol. 409, no. 7, pp. 1219–1228, 2011. View at: Publisher Site | Google Scholar
  23. S. J. Choi, J. M. Oh, and J. H. Choy, “Toxicological effects of inorganic nanoparticles on human lung cancer A549 cells,” Journal of Inorganic Biochemistry, vol. 103, no. 3, pp. 463–471, 2009. View at: Publisher Site | Google Scholar
  24. E. Planus, S. Galiacy, M. Matthay et al., “Role of collagenase in mediating in vitro alveolar epithelial wound repair,” Journal of Cell Science, vol. 112, no. 2, pp. 243–252, 1999. View at: Google Scholar
  25. J. Burg, V. Krump-Konvalinkova, F. Bittinger, and C. J. Kirkpatrick, “GM-CSF expression by human lung microvascular endothelial cells: in vitro and in vivo findings,” American Journal of Physiology, vol. 283, no. 2, pp. L460–L467, 2002. View at: Google Scholar
  26. M. A. Matthay, H. G. Folkesson, and C. Clerici, “Lung epithelial fluid transport and the resolution of pulmonary edema,” Physiological Reviews, vol. 82, no. 3, pp. 569–600, 2002. View at: Google Scholar
  27. W. S. Cho, R. Duffn, C. A. Poland et al., “Metal oxide nanoparticles induce unique infammatory footprints in the lung: important implications for nanoparticle testing,” Environmental Health Perspectives, vol. 118, no. 12, pp. 1699–1706, 2010. View at: Publisher Site | Google Scholar
  28. W. S. Cho, R. Duffin, M. Bradley et al., “NiO and Co3O4 nanoparticles induce lung DTH-like responses and alveolar lipoproteinosis,” European Respiratory Journal, vol. 39, pp. 546–557, 2012. View at: Google Scholar
  29. A. Montiel-Davalos, J. L. Ventura-Gallegos, E. Alfaro-Moreno et al., “TiO2 nanoparticles induce dysfunction and activation of human endothelial cells,” Chemical Research in Toxicology, vol. 25, pp. 920–930, 2012. View at: Google Scholar
  30. J. Sun, S. Wang, D. Zhao, F. H. Hun, L. Weng, and H. Liu, “Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells—cytotoxicity, permeability, and inflammation of metal oxide nanoparticles,” Cell Biology and Toxicology, vol. 27, pp. 333–342, 2011. View at: Publisher Site | Google Scholar
  31. B. Fahmy and S. A. Cormier, “Copper oxide nanoparticles induce oxidative stress and cytotoxicity in airway epithelial cells,” Toxicology In Vitro, vol. 23, no. 7, pp. 1365–1371, 2009. View at: Publisher Site | Google Scholar
  32. M. Papritz, C. Pohl, C. Wübbeke et al., “Side-specific effects by cadmium exposure: apical and basolateral treatment in a coculture model of the blood-air barrier,” Toxicology and Applied Pharmacology, vol. 245, no. 3, pp. 361–369, 2010. View at: Publisher Site | Google Scholar
  33. S. F. Van Eeden, W. C. Tan, T. Suwa et al., “Cytokines involved in the systemic inflammatory response induced by exposure to particulate matter air pollutants (PM10),” American Journal of Respiratory and Critical Care Medicine, vol. 164, no. 5, pp. 826–830, 2001. View at: Google Scholar
  34. M. Kolb, P. J. Margetts, D. C. Anthony, F. Pitossi, and J. Gauldie, “Transient expression of IL-1β induces acute lung injury and chronic repair leading to pulmonary fibrosis,” Journal of Clinical Investigation, vol. 107, no. 12, pp. 1529–1536, 2001. View at: Google Scholar
  35. W. Möller, K. Felten, K. Sommerer et al., “Deposition, retention, and translocation of ultrafine particles from the central airways and lung periphery,” American Journal of Respiratory and Critical Care Medicine, vol. 177, no. 4, pp. 426–432, 2008. View at: Publisher Site | Google Scholar
  36. C. Brandenberger, B. Rothen-Rutishauser, C. Mühlfeld et al., “Effects and uptake of gold nanoparticles deposited at the air-liquid interface of a human epithelial airway model,” Toxicology and Applied Pharmacology, vol. 242, no. 1, pp. 56–65, 2010. View at: Publisher Site | Google Scholar
  37. Z. E. Allouni, P. J. Høl, M. A. Cauqui, N. R. Gjerdet, and M. R. Cimpan, “Role of physicochemical characteristics in the uptake of TiO2 nanoparticles by fibroblasts,” Toxicology In Vitro, vol. 26, pp. 469–479, 2012. View at: Google Scholar
  38. R. P. Singh and P. Ramarao, “Cellular uptake, intracellular trafficking and cytotoxicity of silver nanoparticles,” Toxicology Letters, vol. 213, pp. 249–259, 2012. View at: Google Scholar
  39. E. Belade, L. Armand, L. Martinon et al., “A comparative transmission electron microscopy study of titamium dioxide and carbon black nanoparticles uptake in human lung epithelial and fibroblast cell lines,” Toxicology In Vitro, vol. 26, pp. 57–66, 2012. View at: Google Scholar
  40. J. Geys, L. Coenegrachts, J. Vercammen et al., “In vitro study of the pulmonary translocation of nanoparticles: a preliminary study,” Toxicology Letters, vol. 160, no. 3, pp. 218–226, 2006. View at: Publisher Site | Google Scholar

Copyright © 2013 Rossella Bengalli et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.